Your browser doesn't support javascript.
loading
Study of the effects of interferon ß-1a on hospitalized patients with COVID-19: SBMU Taskforce on the COVIFERON study.
Fallahzadeh, Mohammad; Pourhoseingholi, Mohamad A; Boroujeni, Masoud G; Besharati, Sajad; Mardani, Masoud; Shabani, Minoosh; Shokouhi, Shervin; Amirdosara, Mahdi; Hajiesmaeili, Mohammadreza; Gachkar, Latif; Roshan, Baran; Zangi, Masoud; Mirmomeni, Golshan; Irvani, Seyed S N; Alavi Darazam, Ilad.
Afiliação
  • Fallahzadeh M; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Pourhoseingholi MA; SBMU Taskforce on the COVIFERON Study, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Boroujeni MG; SBMU Taskforce on the COVIFERON Study, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Besharati S; Gastroenterology and Liver Diseases Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mardani M; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Shabani M; SBMU Taskforce on the COVIFERON Study, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Shokouhi S; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Amirdosara M; SBMU Taskforce on the COVIFERON Study, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hajiesmaeili M; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Gachkar L; SBMU Taskforce on the COVIFERON Study, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Roshan B; Department of Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Zangi M; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mirmomeni G; SBMU Taskforce on the COVIFERON Study, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Irvani SSN; Department of Infectious Diseases and Tropical Medicine, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Alavi Darazam I; Infectious Diseases and Tropical Medicine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
J Med Virol ; 94(4): 1488-1493, 2022 04.
Article em En | MEDLINE | ID: mdl-34821387
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Interferon beta-1a / Tratamento Farmacológico da COVID-19 / Tempo de Internação Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Interferon beta-1a / Tratamento Farmacológico da COVID-19 / Tempo de Internação Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article